Emvision Medical Devices Share Price and Company Fundamentals
Last traded: Today at 5:59 AM
EMvision Medical Devices Limited engages in the research, development, and commercialization of imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, and other medical imaging needs. The company has a strategic collaboration with Keysight Technologies Malaysia Sdn Bhd to develop a personalized vector network analysis solution for medical imaging in the healthcare sector. EMvision Medical Devices Limited was founded in 2017 and is based in Macquarie Park, Australia.
|Primary activities||Development and commercialisation of medical imaging technology.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||65 Epping Road Level 4 Suite 4.01 Macquarie Park NSW 2113 Australia|
|Phone / Fax||61 2 8667 5337 /|
|Share registry||LINK MARKET SERVICES LIMITED|
Emvision Medical Devices does not pay dividends.
As of May 2021, following are the company executives and directors listed on Emvision Medical Devices.
|Dr. Ronald Peter Weinberger||CEO, MD & Director||260k|
|Mr. Scott Kirkland||Exec. Director||224.47k|
|Ms. Emma Waldon||CFO & Company Sec.||44|
|Dr. Konstanty Bialkowski||Head of Technology Devel.|
|Prof. Stuart Crozier B.E., M.Sc., Ph.D.||Chairman of Clinical Advisory Board & Chief Scientific Officer|
|Mr. Robert Tiller||Head of Design|
|Ms. Ruth Cremin||Head of Quality & Regulatory Affairs|
|Ms. Forough Khandan||Head of Program Management|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Emvision Medical Devices is 206.63M and its enterprise value is 193.87M. The enterprise value to revenue ratio of EMV is 93.64.
The EMV's stocks Beta value is 1.77 making it 77% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Emvision Medical Devices (EMV)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Emvision Medical Devices (ASX:EMV) Frequently Asked Questions
1. What is Emvision Medical Devices's Stock Symbol?
Emvision Medical Devices trades on ASX under the ticker symbol "EMV".
2. What is Emvision Medical Devices's stock price today?
One share of EMV stock can currently be purchased for approximately $2.92.
3. How can I contact Emvision Medical Devices?
Emvision Medical Devices's mailing address is 65 Epping Road Level 4 Suite 4.01 Macquarie Park NSW 2113 Australia. The company can be reached via phone at 61 2 8667 5337.
4. What is Emvision Medical Devices's official website?
The official website of Emvision Medical Devices is http://www.emvision.com.au.
5. Which share registry manages Emvision Medical Devices's stock?
Emvision Medical Devices's stock is managed by LINK MARKET SERVICES LIMITED.